Frankfurt
17.07.26 | 15:25
3,840 Euro
+4,35 % +0,160
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Cantor Fitzgerald initiates Inventiva stock with overweight rating | 5 | Investing.com | ||
| 09.07. | INVENTIVA: Inventiva Announces Completion of the EIB Warrant Restructuring with the Issuance of New EIB Warrants | 861 | GlobeNewswire (Europe) | Daix (France), New York City (New York, United States), July 9, 2026 - Inventiva (Euronext Paris and NASDAQ: IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focused on... ► Artikel lesen | |
| 06.07. | Inventiva S.A. - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 02.07. | INVENTIVA: Results of the Votes of the Combined Shareholders' General Meeting of June 30, 2026 | 479 | GlobeNewswire (Europe) | Daix (France), New York City (New York, United States), July 2, 2026 - Inventiva (Euronext Paris and NASDAQ: IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focused on... ► Artikel lesen | |
| INVENTIVA SA ADR Aktie jetzt für 0€ handeln | |||||
| 30.06. | Inventiva S.A. (IVA) is One of the Best Stocks Under $10 Offering More Than 50% Upside | 9 | Insider Monkey | ||
| 12.06. | INVENTIVA: Inventiva announces Repayment of EIB Loans, Repurchase of a portion of EIB Warrants and the Issuance of the first two tranches under New Debt Financing | 594 | GlobeNewswire (Europe) | Repaid in full the existing EIB Loans1 in an amount of approximately €62 million and completed repurchase of all 2,266,023 existing EIB Tranche A Warrants and 700,000 of existing EIB Tranche B Warrants2... ► Artikel lesen | |
| 12.06. | Inventiva S.A. - 6-K, Report of foreign issuer | 12 | SEC Filings | ||
| 09.06. | INVENTIVA: Combined General Meeting of June 30, 2026 - Availability of the Preparatory Documents | 741 | GlobeNewswire (Europe) | Daix (France), New York City (New York, United States), June 9,2026 - Inventiva (Euronext Paris and NASDAQ: IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focused on... ► Artikel lesen | |
| 09.06. | INVENTIVA: Statement of Total Voting Rights and Shares Forming The Company's Share Capital as of May 22, 2026 | 372 | GlobeNewswire (Europe) | Article R. 22-10-23 of the French Commercial Code
Market: Euronext Paris
ISIN code / Mnemo: FR0013233012 / IVA
Web site: www.inventivapharma.com
DateNumber of Shares OutstandingTotal... ► Artikel lesen | |
| 03.06. | Inventiva S.A. - 6-K, Report of foreign issuer | 12 | SEC Filings | ||
| 02.06. | INVENTIVA: Inventiva Announces a Comprehensive Capital Structure Optimization including Debt and Equity Financing in Advance of the Anticipated Phase 3 Readout | 743 | GlobeNewswire (Europe) | Secured a new debt financing with funds and accounts managed by BlackRock and Claret Capital Partners, respectively for up to €130 million in committed tranches, subject to conditions, plus an additional... ► Artikel lesen | |
| 02.06. | INVENTIVA: Inventiva Announces Trading Resumption of its Ordinary Shares on Euronext Paris | 342 | GlobeNewswire (Europe) | Daix (France), New York City (New York, United States), June 2, 2026 - Inventiva (Euronext Paris and NASDAQ: IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focused on... ► Artikel lesen | |
| 02.06. | INVENTIVA: Inventiva Announces Temporary Trading Halt of its Ordinary Shares on Euronext Paris | 791 | GlobeNewswire (Europe) | Daix (France), New York City (New York, United States), June 2, 2026 - Inventiva (Euronext Paris and NASDAQ: IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focused on... ► Artikel lesen | |
| 27.05. | Inventiva S.A reports Q1 results | 2 | Seeking Alpha | ||
| 26.05. | INVENTIVA: Inventiva Reports 2026 First Quarter Financial Information | 832 | GlobeNewswire (Europe) | Cash and cash equivalents at €75.0 million, and €121.5 million in short-term deposits2
Daix (France), New York City (New York, United States), May 26, 2026 - Inventiva (Euronext Paris and NASDAQ:... ► Artikel lesen | |
| 22.05. | Inventiva S.A. - 6-K, Report of foreign issuer | 4 | SEC Filings | ||
| 21.05. | INVENTIVA: Inventiva to Present at 2026 Jefferies Global Healthcare Conference | 410 | GlobeNewswire (Europe) | Daix (France), New York (United States), May 21, 2026 - Inventiva (Euronext Paris and NASDAQ: IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focused on the development... ► Artikel lesen | |
| 13.05. | INVENTIVA: Inventiva to Present Abstracts at the EASL Congress 2026 | 460 | GlobeNewswire (Europe) | Daix (France), New York City (New York, United States), May 13, 2026 - Inventiva (Euronext Paris and NASDAQ: IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focused on... ► Artikel lesen | |
| 01.05. | Inventiva appoints Axel-Sven Malkomes as Chief Financial Officer | 9 | PMLiVE | ||
| 22.04. | Inventiva announces CFO appointment | 2 | Seeking Alpha |
1 2 3 Weiter >>
57 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EYEPOINT | 11,600 | +1,75 % | EyePoint, Inc.: EyePoint Appoints Tarek S. Hassan, M.D., as Chief Strategic Science Officer | WATERTOWN, Mass., July 13, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with... ► Artikel lesen | |
| EDWARDS LIFESCIENCES | 75,60 | -1,56 % | Edwards Lifesciences Appoints Theodora Mistras As Chief Financial Officer |
WASHINGTON (dpa-AFX) - Edwards Lifesciences Corporation (EW) said that it has appointed Theodora Mistras as chief financial officer effective at the end of May.Mistras will join Edwards from... ► Artikel lesen | |
| HAPPY BELLY FOOD GROUP | 0,975 | -2,01 % | Happy Belly Food Group Inc.: Happy Belly Food Group's Heal Wellness QSR Announces the Grand Opening of its Newest Location in Downtown Toronto, Ontario | Toronto, Ontario--(Newsfile Corp. - July 17, 2026) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leading consolidator of emerging restaurant brands... ► Artikel lesen | |
| JAZZ PHARMACEUTICALS | 217,80 | +2,88 % | AbCellera Biologics Inc.: Jazz Pharmaceuticals and AbCellera Announce Collaboration to Discover Next-Generation T-cell Engaging Multispecific Antibodies | The collaboration includes $56 million in upfront payments to AbCellera and up to $792 million in potential option fees and milestone payments for any program Jazz exercises its option to develop... ► Artikel lesen | |
| DAIICHI SANKYO | 14,700 | -0,01 % | EQS-News: Daiichi Sankyo Deutschland GmbH: Bundesgesundheitsministerin Warken besucht Produktions- und Entwicklungsstandort von Daiichi Sankyo in Pfaffenhofen | EQS-News: Daiichi Sankyo Deutschland GmbH
/ Schlagwort(e): Stellungnahme/Studie
Bundesgesundheitsministerin Warken besucht Produktions- und Entwicklungsstandort von Daiichi Sankyo... ► Artikel lesen | |
| AYTU BIOPHARMA | 1,900 | -100,00 % | Aytu BioPharma, Inc.: Aytu BioPharma to Present at the Planet MicroCap Las Vegas 2026 Investor Conference on June 17, 2026 | DENVER, CO / ACCESS Newswire / June 1, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous... ► Artikel lesen | |
| RIGEL PHARMACEUTICALS | 35,340 | +1,32 % | Rigel Pharmaceuticals, Inc.: Rigel Appoints Board Member Alison L. Hannah, M.D. as Chief Medical Officer | Dr. Hannah has decades of oncology drug development experience and has served on Rigel's Board of Directors since 2021
She has resigned from Rigel's Board of... ► Artikel lesen | |
| NRX PHARMACEUTICALS | 3,805 | +2,56 % | NRx Pharmaceuticals, Inc.: NRx Pharmaceuticals Responds to Recent Public Statements Regarding Kadima Dispute | WILMINGTON, Del., June 25, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx" or the "Company") today issued the following statement in response to recent public claims made... ► Artikel lesen | |
| TUHURA BIOSCIENCES | 1,910 | -1,04 % | TuHURA Biosciences, Inc.: TuHURA Biosciences Files Investigational New Drug Application for Evaluation of the TBS-2025 VISTA Inhibiting Antibody in Molecularly Defined Subsets of AML and Other Blood Related Cancers | The IND is aligned with guidance previously provided by the U.S. Food and Drug Administration (FDA) on the development pathway for both monotherapy and combination... ► Artikel lesen | |
| CGN MINING | 0,268 | +5,51 % | CLSA Initiates CGN MINING at Outperform, TP at HKD4.75 | ||
| CHINA SHINEWAY PHARMACEUTICAL GROUP | 0,895 | -2,19 % | SHINEWAY PHARM (02877): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 28 MAY 2026 | ||
| FUTURA MEDICAL | 0,001 | 0,00 % | IN BRIEF: Futura Medical disputes European Union patent revocation | ||
| BAYER | 48,460 | +1,55 % | DAX verteidigt Unterstützung - Bayer, Dürr, Infineon, Salzgitter und VW im Check | Der DAX startet zum Wochenschluss mit einer Atempause und verteidigt zunächst die Marke von 25.000 Punkten. Durchwachsene Vorgaben aus Asien und wieder etwas höhere Ölpreise bremsen die Erholung vom... ► Artikel lesen | |
| MERCK KGAA | 136,30 | -1,20 % | Merck KGaA erhält Zulassungserweiterung für Erbitux in der EU | DJ Merck KGaA erhält Zulassungserweiterung für Erbitux in der EU
DOW JONES--Der Darmstädter Pharmakonzern Merck hat in der Europäischen Union eine Zulassungserweiterung für seinen Blockbuster Erbitux... ► Artikel lesen | |
| NOVO NORDISK | 43,950 | -2,42 % | Während alle auf KI schauen: Warum Big Pharma Milliarden in Zelltherapien investiert |
INVENTIVA SA ADR gehört der Branche Pharma an. Der aktuelle Kurs liegt bei 3,840 Euro und damit +4,35 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu INVENTIVA SA ADR finden Sie auf Wallstreet Online.